secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALISADE BIO, INC. (PALI)
CIK:        0001357459
Form:       8-K
Filed at:   2025-12-04T23:59:59+00:00
Accession:  0001493152-25-026195
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Palisade Bio shareholders approve increase in authorized shares to 300M and warrant issuance of up to 8.64M shares
--------------------------------------------------------------------------------

- Authorized common stock increased from 280M to 300M shares via certificate of amendment filed Dec. 3, 2025.
- Stockholders approved issuance of up to 8,637,810 common shares underlying warrants under July 23, 2025 inducement agreement.
- Proposal passed with ~126.3M votes for; quorum of 85.53% of outstanding shares (148.96M) represented.
- Warrant exercise required under Nasdaq Listing Rule 5635 because shares exceed 20% of pre-issuance outstanding.
- Adjournment proposal also approved to allow further solicitation if needed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357459/000149315225026195/0001493152-25-026195-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357459/000149315225026195/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-026195

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer